Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Quince Therapeutics
QNCX
$21M
| $5.12M | ﹤0.01% |
279
-6
| -2% | -$95.4K |
|
1802
CALL
Medtronic
MDT
$113B
| $5.11M | ﹤0.01% |
40,800
-1,100
| -3% | -$142K |
|
1803
Manhattan Associates
MANH
$12.2B
| $5.1M | ﹤0.01% |
33,345
-8,797
| -21% | -$1.37M |
|
1804
PUT
Atlassian
TEAM
$26.4B
| $5.09M | ﹤0.01% |
13,000
| – | – |
|
1805
Kulicke & Soffa
KLIC
$4.39B
| $5.07M | ﹤0.01% |
87,045
-24,981
| -22% | -$1.56M |
|
1806
NETSCOUT
NTCT
$2.82B
| $5.07M | ﹤0.01% |
188,164
+25,409
| +16% | +$704K |
|
1807
Acadia Healthcare
ACHC
$2.53B
| $5.07M | ﹤0.01% |
79,443
+47,254
| +147% | +$2.98M |
|
|
NEX
1808
CALL
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $5.07M | ﹤0.01% |
+1,101,100
| New | +$4.43M |
|
|
HJEN
1809
DELISTED
Direxion Hydrogen ETF
HJEN
| $5.06M | ﹤0.01% |
250,000
| – | – |
|
|
TPH
1810
DELISTED
Tri Pointe Homes
TPH
| $5.05M | ﹤0.01% |
240,056
+60,599
| +34% | +$1.37M |
|
|
AZEK
1811
DELISTED
The AZEK Co
AZEK
| $5.03M | ﹤0.01% |
137,812
+29,542
| +27% | +$1.15M |
|
1812
National Beverage
FIZZ
$3.02B
| $5.03M | ﹤0.01% |
95,869
-7,640
| -7% | -$356K |
|
1813
Weibo
WB
$1.98B
| $5.03M | ﹤0.01% |
105,971
-31,514
| -23% | -$1.7M |
|
1814
Invesco CEF Income Composite ETF
PCEF
$792M
| $5.03M | ﹤0.01% |
210,001
+209,501
| +41,900% | +$5.12M |
|
1815
ICICI Bank
IBN
$107B
| $5.03M | ﹤0.01% |
266,290
-174,515
| -40% | -$3.27M |
|
1816
Lear
LEA
$7.43B
| $5.03M | ﹤0.01% |
32,119
-10,216
| -24% | -$1.67M |
|
|
GSIG
1817
DELISTED
Goldman Sachs Access Investment Grade Corporate 1-5 Year Bond ETF
GSIG
| $5.01M | ﹤0.01% |
100,000
| – | – |
|
1818
First Trust Rising Dividend Achievers ETF
RDVY
$24.6B
| $5M | ﹤0.01% |
105,333
-4,049
| -4% | -$196K |
|
|
NGM
1819
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $5M | ﹤0.01% |
237,827
+137,509
| +137% | +$3.03M |
|
1820
Ligand Pharmaceuticals
LGND
$5.8B
| $4.98M | ﹤0.01% |
57,277
+893
| +2% | +$69.1K |
|
1821
Apple Hospitality REIT
APLE
$3.97B
| $4.98M | ﹤0.01% |
316,424
-89,241
| -22% | -$1.34M |
|
1822
PUT
Marathon Petroleum
MPC
$90.6B
| $4.97M | ﹤0.01% |
80,400
| – | – |
|
|
GXDW
1823
Global X Funds Global X Dorsey Wright Thematic ETF
GXDW
$5.85M
| $4.96M | ﹤0.01% |
100,000
-100,000
| -50% | -$5.14M |
|
1824
Pebblebrook Hotel Trust
PEB
$2.2B
| $4.95M | ﹤0.01% |
220,896
-375,796
| -63% | -$8.32M |
|
1825
Ryanair
RYAAY
$30.1B
| $4.94M | ﹤0.01% |
112,150
-42,135
| -27% | -$1.82M |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.